Healthcare Transactions & Strategy

We provide deep and broad healthcare expertise for transactional and strategic situations, and advise on all aspects of the healthcare market, including: public policy, government payers, commercial payers, compliance, and operations. We deliver government experience, industry experience, and extensive data analytics.

BRG’s Healthcare Transactions and Strategy practice provides clients valuable insight throughout the transaction process and to inform strategic initiatives.

With deep M&A buy-side experience, our professionals provide an integrated deliverable across capabilities including regulatory and reimbursement, primary market research, strategy, data analytics, and compliance.

Our professionals have worked with more than 300 private equity firms and many leading companies on more than 3,000 M&A transactions. With decades of experience in both the public and private sectors, our professionals offer unmatched expertise for investors, companies, and advocacy groups when navigating today’s evolving regulatory and reimbursement environment. Our team includes former policymakers and regulatory professionals from the executive branch, including the Centers for Medicare and Medicaid Services/Health and Human Services and the White House, as well as from Capitol Hill, trade associations, and state governments.

Healthcare Investment Index

BRG’s seventh-annual Healthcare Investment Index highlights emerging areas of investor interest and thesis themes based on a survey of more than 120 senior-level healthcare investors.

The index includes a look back at priorities over the last seven years, the top five strategic thesis areas, and a review of 2024 areas of interest.

Learn more now